Dual Targeting of Orphan Nuclear Receptors NR4A1 and NR4A2 for Nonhormonal Endometriosis Therapy
Endocrinology · 2025
DOI: 10.1210/endocr/bqaf144 ↗Kurz gefasst
Fachartikel in der Zeitschrift Endocrinology, 2025. Verfasst von Wai Ning Tiffany Tsui und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Veterinary Physiology and Pharmacology, College of Veterinary Medicine, Texas A&M University, College Station, TX 77843, USA. Hauptthemen laut MEDLINE: Endometriosis, Nuclear Receptor Subfamily 4, Group A, Member 1, Nuclear Receptor Subfamily 4, Group A, Member 2, Indoles. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 62 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Institute of Child Health and Human Development, NIEHS NIH HHS, Syd Kyle Chair endowment.
Abstract (Originalsprache)
Previous studies show that orphan nuclear receptor 4A1 (NR4A1) regulates endometriotic cell growth, survival, estrogen receptor β (ERβ), mechanistic target of rapamycin signaling and fibrosis. NR4A2 is also expressed in epithelial and stromal derived endometriotic cells, and in this study the effects of 1,1-bis(3′-indolyl)-(3,5-disubstitutedphenyl)methane (DIM-3,5) dual NR4A1/nuclear receptor 4A2 (NR4A2) ligands and knockdown of NR4A1 and NR4A2 were investigated. The dual NR4A1/2 DIM-3,5 analogs inhibited previously identified proendometriotic pathways and gene products, and they also inhibited TWIST1 and multiple markers associated with epithelial-to-mesenchymal transition (EMT). The results show that both NR4A1 and NR4A2 regulate the same pathways, including endometriotic cell growth, survival, and migration and also some of the same genes in endometriotic epithelial and stromal cells. For example, DIM-3,5 compounds downregulate ERβ in stromal but not epithelial endometriotic cells, and this response is NR4A1- and not NR4A2-dependent. Among the EMT-related markers, claudin-1 is induced by DIM-3,5 ligands and after knockdown of NR4A1 or NR4A2 in both epithelial and stromal cells. Most of the EMT markers are downregulated by DIM-3,5 ligands and are coregulated by NR4A1 and NR4A2. In vivo studies showed that DIM-3,5-Cl2 significantly reduced the growth of endometriotic lesions in a mouse model without inducing cytotoxicity during treatment. Thus, DIM-3,5 derivatives simultaneously suppress NR4A1- and NR4A2-dependent endometriosis progression effectively and represent a promising nonhormonal therapeutic strategy to replace current hormone-based treatments that can be associated with adverse effects.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Veterinary Physiology and Pharmacology, College of Veterinary Medicine, Texas A&M University, College Station, TX 77843, USA.
- Department of Molecular & Cell Biology, Baylor College of Medicine, Houston, TX 77030, USA.
- Department of Veterinary Pathobiology, College of Veterinary Medicine, Texas A&M University, College Station, TX 77845, USA.
ORCID-Profile: Sang Jun Han, Stephen Safe
Förderung
- National Institute of Child Health and Human Development
- NIEHS NIH HHS
- Syd Kyle Chair endowment
- Texas AgriLife
- NICHD NIH HHS
- Congressionally Directed Medical Research Programs
- National Institute of Environmental Health Sciences
Zitieren
APA
Tsui, W. N. T., Park, Y., Upadhyay, S., Kim, D. M., Zhang, L., Wright, G., Hailemariam, A., Oany, A. R., Han, S. J., & Safe, S. (2025). Dual Targeting of Orphan Nuclear Receptors NR4A1 and NR4A2 for Nonhormonal Endometriosis Therapy. Endocrinology. https://doi.org/10.1210/endocr/bqaf144
Vancouver
Tsui WNT, Park Y, Upadhyay S, Kim DM, Zhang L, Wright G, et al. Dual Targeting of Orphan Nuclear Receptors NR4A1 and NR4A2 for Nonhormonal Endometriosis Therapy. Endocrinology. 2025. doi:10.1210/endocr/bqaf144
BibTeX
@article{Tsui2025,
author = {Tsui, Wai Ning Tiffany and Park, Yuri and Upadhyay, Srijana and Kim, Da Mi and Zhang, Lei and Wright, Gus and Hailemariam, Amanuel and Oany, Arafat Rahman and Han, Sang Jun and Safe, Stephen},
title = {Dual Targeting of Orphan Nuclear Receptors NR4A1 and NR4A2 for Nonhormonal Endometriosis Therapy},
journal = {Endocrinology},
year = {2025},
doi = {10.1210/endocr/bqaf144}
}
EUVIMED